Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Genmab A/S

    OTC: GNMSF · Real-Time Price · USD
    222.50
    -1.80 (-0.80%)
    At close: Jun 16, 2025, 3:13 PM

    Genmab A/S Statistics

    Share Statistics

    Genmab A/S has 61.48M shares outstanding. The number of shares has increased by -2.46% in one year.

    Shares Outstanding

    n/a
    		 61.48M

    Shares Change (YoY)

    n/a
    		 -2.46%

    Shares Change (QoQ)

    n/a
    		 0.04%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 58.49M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 117.89K, so 0.19% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 117.89K

    Short % of Shares Out

    n/a
    		 0.19%

    Short % of Float

    n/a
    		 0.19%

    Short Ratio (days to cover)

    n/a
    		 982.43

    Valuation Ratios

    The PE ratio is 12.22 and the forward PE ratio is 1.72. Genmab A/S's PEG ratio is 0.14.

    PE Ratio

    n/a
    		 12.22

    Forward PE

    n/a
    		 1.72

    PS Ratio

    n/a
    		 4.45

    Forward PS

    n/a
    		 0.3

    PB Ratio

    n/a
    		 2.61

    P/FCF Ratio

    n/a
    		 12.84

    PEG Ratio

    n/a
    		 0.14
    Financial Ratio History

    Enterprise Valuation

    Genmab A/S has an Enterprise Value (EV) of 87.05B.

    EV / Sales

    n/a
    		 4.04

    EV / EBITDA

    n/a
    		 8.98

    EV / EBIT

    n/a
    		 11.2

    EV / FCF

    n/a
    		 11.66

    Financial Position

    The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.03.

    Current Ratio

    n/a
    		 5.25

    Quick Ratio

    n/a
    		 5.24

    Debt / Equity

    n/a
    		 0.03

    Debt / EBITDA

    n/a
    		 0.11

    Debt / FCF

    n/a
    		 0.14

    Interest Coverage

    n/a
    		 55.86

    Financial Efficiency

    Return on Equity is 21.38% and Return on Invested Capital is 14.13%.

    Return on Equity

    n/a
    		 21.38%

    Return on Assets

    n/a
    		 17.12%

    Return on Invested Capital

    n/a
    		 14.13%

    Revenue Per Employee

    n/a
    		 $8,159,969.67

    Profits Per Employee

    n/a
    		 $2,973,464.75

    Employee Count

    n/a
    		 2,638

    Asset Turnover

    n/a
    		 0.47

    Inventory Turnover

    n/a
    		 15.89

    Taxes

    Income Tax

    n/a
    		 1.32B

    Effective Tax Rate

    n/a
    		 14.4%

    Stock Price Statistics

    The stock price has increased by -15.75% in the last 52 weeks. The beta is 0.82, so Genmab A/S's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.82

    52-Week Price Change

    n/a
    		 -15.75%

    50-Day Moving Average

    n/a
    		 202.46

    200-Day Moving Average

    n/a
    		 216.22

    Relative Strength Index (RSI)

    n/a
    		 67.92

    Average Volume (20 Days)

    n/a
    		 1,847

    Income Statement

    In the last 12 months, Genmab A/S had revenue of 21.53B and earned 7.84B in profits. Earnings per share was 122.21.

    Revenue

    n/a
    		 21.53B

    Gross Profit

    n/a
    		 20.54B

    Operating Income

    n/a
    		 6.7B

    Net Income

    n/a
    		 7.84B

    EBITDA

    n/a
    		 9.7B

    EBIT

    n/a
    		 9.28B

    Earnings Per Share (EPS)

    n/a
    		 122.21
    Full Income Statement

    Balance Sheet

    The company has 9.86B in cash and 1.03B in debt, giving a net cash position of 8.83B.

    Cash & Cash Equivalents

    n/a
    		 9.86B

    Total Debt

    n/a
    		 1.03B

    Net Cash

    n/a
    		 8.83B

    Retained Earnings

    n/a
    		 23.55B

    Total Assets

    n/a
    		 6.59B

    Working Capital

    n/a
    		 3.28B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 7.77B and capital expenditures -304M, giving a free cash flow of 7.47B.

    Operating Cash Flow

    n/a
    		 7.77B

    Capital Expenditures

    n/a
    		 -304M

    Free Cash Flow

    n/a
    		 7.47B

    FCF Per Share

    n/a
    		 116.33
    Full Cash Flow Statement

    Margins

    Gross margin is 95.42%, with operating and profit margins of 31.14% and 36.44%.

    Gross Margin

    n/a
    		 95.42%

    Operating Margin

    n/a
    		 31.14%

    Pretax Margin

    n/a
    		 42.57%

    Profit Margin

    n/a
    		 36.44%

    EBITDA Margin

    n/a
    		 45.05%

    EBIT Margin

    n/a
    		 31.14%

    FCF Margin

    n/a
    		 34.69%

    Dividends & Yields

    GNMSF does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 8.18%

    FCF Yield

    n/a
    		 7.79%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GNMSF.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $1327.2

    Lynch Upside

    n/a
    		 496.49%

    Graham Number

    n/a
    		 1253.81

    Graham Upside

    n/a
    		 463.51%

    Scores

    Altman Z-Score

    n/a
    		 13.75

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist